Artiva Biotherapeutics, Inc. ( ARTV) - Key Metrics
ARTV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.63 | -$1.05 | -$1.06 |
| 2026Q1 | $0 | -$0.95 | -$0.85 | -$0.86 |
| 2025Q4 | $0 | -$0.85 | -$0.60 | -$0.62 |
| 2025Q3 | $0 | -$0.88 | -$0.78 | -$0.81 |
| 2025Q2 | $0 | -$0.87 | -$0.94 | -$0.99 |
ARTV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.85 |
| 2026Q1 | 0% | -1.69 |
| 2025Q4 | 0% | -1.26 |
| 2025Q3 | 0% | -0.82 |
| 2025Q2 | 0% | -0.43 |
ARTV
Price: $6.46
52 week price:
Earnings Per Share: -3.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 355.4 million